Pharmaceutical Water Market

Pharmaceutical Water Segment is the largest segment driving the growth of Pharmaceutical Water Market


The global Pharmaceutical Water Market is estimated to be valued at US$ 6.26 Bn or Billion in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Pharmaceutical water is water that meets certain regulated standards required for manufacturing and processing of drugs. It is water that has been purified through distillation, reverse osmosis, ion exchange or another purification process and meets certain standards for quality when used for pharmaceutical applications such as drug manufacturing. The purified water supports the quality, efficacy, and safety of the pharmaceutical product.

Market key trends:

One of the key trends in the pharmaceutical water market is the increasing demand for purified water in pharmaceutical manufacturing. With increasing stringency of regulations regarding pharmaceutical quality and purity, the use of purified water compliant with cGMP (current good manufacturing practices) regulations has become crucial in pharmaceutical production processes. Any contamination in water can potentially jeopardize the safety, quality and efficacy of drug products. Pharmaceutical water is thus widely used across various stages of drug manufacturing right from active pharmaceutical ingredient (API) synthesis to tablet pressing and packaging. The need to prevent contamination is expected to drive the demand for purified pharmaceutical grade water over the forecast period.
Here is the content in the requested format:

Market Key Trends:

The pharmaceutical water market has been witnessing rising demand for purified water in compliance with stringent regulations. With increasing quality standards and need for contamination control in pharm production, use of water treatment systems have increased. Technologies like ultrafiltration and RO are being widely adopted by players to produce high purity water as per Pharmacopeia standards. Continuous advancements in water purification membranes and systems will further drive this trend.

SWOT Analysis

Strengths: Environment friendly production methods using purified water. Stringent quality standards mandate use of treated water.
Weaknesses: High capital and maintenance cost of water treatment systems. Require well trained operators for compliant operations.
Opportunities: Expand in emerging Asian and Latin markets with growing generic drug production. Adopt IoT and sensors for predictive maintenance of plants.
Threats: Price competition from local players offering low cost solutions. Potential new regulations around environment standards.

Key Takeaways

The Global Pharmaceutical Water Market Size is expected to witness high growth, exhibiting CAGR of 7.9% over the forecast period, due to increasing adherence to stringent regulations around water quality in pharma production. North America dominated the market in 2023, owing to presence of many large pharmaceutical players and strict norms by FDA and EPA. Asia Pacific is projected to witness fastest growth due to rising generic drug manufacturing in India and China.
The regional analysis is led by North America which holds over 30% share in 2023 owing to strict protocols enforced by regulatory bodies like FDA and EPA. Asia Pacific is expected to exhibit highest CAGR during the forecast period due to expanding pharmaceutical industry in India and China along with growing health awareness.
Key players operating in the Pharmaceutical Water market are Sartorius, Merck KGaA, Thermo Fisher Scientific Inc., GENERAL ELECTRIC, Danaher Corporation, SUEZ Water Technologies & Solutions, Veolia Water Solutions and Technologies, Evoqua Water Technologies LLC, Aqua Solutions, Inc., Baxter International Inc.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it